From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, FDA, Rockville, MD 20857.
D000163:Acquired Immunodeficiency Syndrome; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D015828:Eye Infections, Viral / Q000188:drug therapy*; D005515:Food Labeling / Q000331:legislation & jurisprudence*; D017245:Foscarnet; D006801:Humans; D006854:Hydrocortisone / Q000600:supply & distribution*; D004366:Nonprescription Drugs / Q000600:supply & distribution; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012173:Retinitis / Q000188:drug therapy* / Q000382:microbiology; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D004366:Nonprescription Drugs; D017245:Foscarnet; D010746:Phosphonoacetic Acid; D006854:Hydrocortisone